fasudil has been researched along with Hemorrhage in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Hemorrhage: Bleeding or escape of blood from a vessel.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Detter, MR | 1 |
| Shenkar, R | 1 |
| Benavides, CR | 1 |
| Neilson, CA | 1 |
| Moore, T | 1 |
| Lightle, R | 1 |
| Hobson, N | 1 |
| Shen, L | 1 |
| Cao, Y | 1 |
| Girard, R | 1 |
| Zhang, D | 1 |
| Griffin, E | 1 |
| Gallione, CJ | 1 |
| Awad, IA | 1 |
| Marchuk, DA | 1 |
1 other study available for fasudil and Hemorrhage
| Article | Year |
|---|---|
Novel Murine Models of Cerebral Cavernous Malformations.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acute Disease; Animals; Apoptosis Regulatory Proteins | 2020 |